Acquiring evidence for precision prostate cancer care.
| dc.contributor.author | Mateo, J | |
| dc.contributor.author | Carreira, S | |
| dc.contributor.author | de Bono, JS | |
| dc.date.accessioned | 2017-08-14T14:38:01Z | |
| dc.date.issued | 2017-05-01 | |
| dc.identifier.citation | Annals of oncology : official journal of the European Society for Medical Oncology, 2017, 28 (5), pp. 916 - 917 | |
| dc.identifier.issn | 0923-7534 | |
| dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/776 | |
| dc.identifier.eissn | 1569-8041 | |
| dc.identifier.doi | 10.1093/annonc/mdx105 | |
| dc.format | ||
| dc.format.extent | 916 - 917 | |
| dc.language | eng | |
| dc.language.iso | eng | |
| dc.publisher | OXFORD UNIV PRESS | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | |
| dc.subject | Humans | |
| dc.subject | Prostatic Neoplasms | |
| dc.subject | Male | |
| dc.title | Acquiring evidence for precision prostate cancer care. | |
| dc.type | Journal Article | |
| rioxxterms.versionofrecord | 10.1093/annonc/mdx105 | |
| rioxxterms.licenseref.uri | https://creativecommons.org/licenses/by-nc/4.0 | |
| rioxxterms.licenseref.startdate | 2017-05 | |
| rioxxterms.type | Journal Article/Review | |
| dc.relation.isPartOf | Annals of oncology : official journal of the European Society for Medical Oncology | |
| pubs.issue | 5 | |
| pubs.notes | Not known | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Cancer Biomarkers | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Cancer Biomarkers | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Prostate Cancer Targeted Therapy Group | |
| pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Cancer Biomarkers | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Cancer Biomarkers | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Prostate Cancer Targeted Therapy Group | |
| pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
| pubs.publication-status | Published | |
| pubs.volume | 28 | |
| pubs.embargo.terms | Not known | |
| icr.researchteam | Cancer Biomarkers | |
| icr.researchteam | Prostate Cancer Targeted Therapy Group | |
| dc.contributor.icrauthor | Carreira, Suzanne | |
| dc.contributor.icrauthor | De Bono, Johann |
Files in this item
This item appears in the following collection(s)
Except where otherwise noted, this item's license is described
as
https://creativecommons.org/licenses/by/4.0